Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry.
Sebastian E BeyerCamden HarrellSteven MullaneValentina KutyifaMalini MadhavanJonathan P PicciniGaurav A UpadhyayJames E IpGeorge ThomasChristopher F LiuSteven M MarkowitzDavid HayesBruce B LermanJim W CheungPublished in: Journal of the American Heart Association (2024)
Adoption of SRP is low in real-world clinical practice. Age, clinical variables, and geographic factors are associated with use of SRP. In this study, SRP-associated decrease in mortality was limited to patients without ischemic heart disease.